HighTower Advisors
ORGO icon

HighTower Advisors’s Organogenesis Holdings ORGO Stock Holding History

HighTower Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,673
Closed -$119K – 3793
2023
Q3 		$119K Buy
+36,673
New +$117K ﹤0.01% 3062

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

HighTower Advisors's ORGO Position: Q4 2023 in Review

HighTower Advisors sold out of Organogenesis Holdings (ORGO) in Q4 2023, closing a stake of 36,673 shares — an estimated $119K sold.

HighTower Advisors first reported a position in ORGO in Q3 2023 and held it in 1 quarter. The position peaked at $119K in Q3 2023. 108 funds tracked by Wall St. Rank hold ORGO as of Q4 2023.

  • HighTower Advisors reported no remaining Organogenesis Holdings position as of Q4 2023 after selling out during the quarter.
  • HighTower Advisors sold 36,673 Organogenesis Holdings shares in Q4 2023, an estimated $119K.
  • HighTower Advisors first reported a position in Organogenesis Holdings in Q3 2023 and held it in 1 quarter.
  • HighTower Advisors's Organogenesis Holdings position peaked at $119K in Q3 2023.
  • 108 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2023.

Based on HighTower Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.